Navigation Links
FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
Date:3/11/2008

cations generally due to restoration of muscle function (8.0%) and dysgeusia (12.6%).

About ZEMURON

ZEMURON (rocuronium bromide) is a non-depolarizing muscle relaxant. It was introduced in the United States in 1994 and is one of the most widely used muscle relaxants in the United States, Canada and many European countries (where it is marketed under the brand name ESMERON). It was approved for use in Japan on July 31, 2007, under the brand name ESLAX. To date, it has been used in over 140 million patients worldwide, including an estimated 20 million patients in 2006.

Important Safety Information About ZEMURON

There have been rare reports of severe anaphylactic reactions to ZEMURON (rocuronium bromide) Injection, including some that have been life threatening. Clinicians should be prepared for the possibility of these reactions and take the necessary precautions, including the immediate availability of emergency treatment. ZEMURON Injection should be administered by experienced clinicians who are familiar with the drug's actions and the possible complications of its use. For Full Prescribing Information please go to http://www.zemuron.com or http://www.esmeron.com.

About Schering-Plough

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. In November 2007, Schering-Plough acquired Organon BioSciences, with its Organon human health and Intervet animal health businesses, marking a pivotal step in the company's ongoing transformation. Schering-Plough's vision is to "Earn Trust, Every Day" with the do
'/>"/>

SOURCE Schering-Plough
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
2. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
3. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
4. Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
5. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
6. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
7. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
8. Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
9. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
10. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
11. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker.c...available in its catalogue: ,, United States D...5 ,, http://www.reportlinker.com/p0158733/Uni...casts-to-2015.html ,, United States Dental Dev...Summary ,, This report is an essential source ...
(Date:11/25/2009)..., WALTHAM, Mass., Nov. 25 Accordin...uthority on medical technology market intelligence...ion devices will continue to see rapid growth over...lowdown. MRG,s US Markets for Trauma Devices 20...ly dynamic over the next five years, with competit...
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker.c...available in its catalogue: ,, Intranasal Drug...://www.reportlinker.com/p0164267/Intranasal-Drug-D...he US intranasal drug delivery market is witnessin...e delivery of conventional local therapeutic drugs...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Sperm May Play Role in Transmission of HIV 60062 1Waste in the U S Healthcare System Pegged at 24700 Billion in Report From Thomson Reuters 60058 1Waste in the U S Healthcare System Pegged at 24700 Billion in Report From Thomson Reuters 60058 2AMERIGROUP Announces Preliminary Third Quarter Results 60054 1AMERIGROUP Announces Preliminary Third Quarter Results 60054 2AMERIGROUP Announces Preliminary Third Quarter Results 60054 3AMERIGROUP Announces Preliminary Third Quarter Results 60054 4AMERIGROUP Announces Preliminary Third Quarter Results 60054 5
...agen, Inc. (Amex: ILE ) today announced that th...ation (BLA) for Isolagen Therapy(TM), a novel, fir...wrinkles/nasolabial folds, to the U.S. Food and Dr...solabial folds Phase III trials were conducted und...BLA submission is a significant regulatory milesto...
...um Therapeutics (NYSE Alternext US: CXM) and its o...orted that positive clinical findings demonstratin...lized manual cooling techniques during robotic-ass...hed in the April 2009 issue of Urology and is no...article/S0090-4295(08)01953-5/abstract . The Hyp...
Other Medicine Technology:Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration 2Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration 3Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration 4Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 2Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 3Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 4Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 5Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 6Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 7Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 8
(Date:11/27/2009)... Shamir Optical Industry...vider of innovative products and technology to the...board of directors had declared a dividend distrib...proximately NIS 37.62 million based on the Novembe...proximately US$ 0.609 (approximately NIS 2.3 based...
(Date:11/27/2009)...ade; announced today that Spectrum Health (Grand R...rise orthopedic templating solution and its Trauma... (PRWEB) November 27, 2009 -- Voyant Health&... Rapids, Michigan) has licensed its TraumaCad Ente...maCad Extend workflow solution, to allow its ortho...
(Date:11/26/2009)...Newswire/ -- The diabetes population in the United...and annual medical spending on the disease is proj...day, according to a study published in the Decembe...g Diabetes ® Program (NCDP), a program of Nov...m the University of Chicago. ,, According to th...
(Date:11/26/2009)...from the North Pole, Textsanta.net lets parents si... North Pole, AK (PRWEB) --... at the North Pole Santa Claus has added SMS text ... informed of his Christmas progress at the North P...t have identified a large and growing percentage o...
(Date:11/25/2009)...ire-USNewswire/ -- When most people hear the acron...ractor can also give patients the help they need. ...h is where your jaw (mandible) contacts/connects w...mmon symptoms associated with TMJ dysfunction are ... But many other symptoms can be caused from TMJ d...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...ional Products, Inc.,(PPI) has been commissioned t...ltimore, Maryland with a Clinical Skills and Simul...is center is on the eighth floor of the,outpatient...skills before they perform a procedure on or inter...
... Company,(Amex: FHC ) today announced that its Ch...ncial Officer, Donna Felch, will present at the Gr...h and 28th, 2008, at the Westin,Fort Lauderdale Ho... session., About the Growth and Value Investor Co...
...ent Approved in Nine Years for Children Sufferi...isease, ABBOTT PARK, Ill., Feb. 22 Abbott (NYSE:...and Drug Administration (FDA),approval to market H...n patients four years of age and older. In the,U.S...
...centric Medical,Inc., the global leader in devices...ay announced that results from the use of its Merc... in seventeen separate presentations,at the Intern...val System in patients suffering from acute ischem...
...Campaign with Launch of Online Video, Contest wit...Commercial,Jonas Brothers Surprise 750 Students at... Announce New Breakfast BREAKS Retail Product, WO...tional campaign to raise awareness about the,impor...
...ealth-care system cited as factors , , FRI...significantly higher prevalence of stroke than the...tional risk factors and barriers to health care fa...men had almost twice the chances of having a strok...
Other Medicine News:Health News:Professional Products, Inc. Integrates Clinical Skills and Simulation Center at the Johns Hopkins Hospital 2Health News:The Female Health Company to Present at Growth and Value Investor Conference in Ft. Lauderdale 2Health News:The Female Health Company to Present at Growth and Value Investor Conference in Ft. Lauderdale 3Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 2Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 3Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 4Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 5Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 6Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 7Health News:2008 International Stroke Conference Highlights Impact of Merci Retrieval System 2Health News:Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 2Health News:Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 3Health News:Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 4Health News:Stroke More Prevalent in U.S. Than in Europe 2
7.75mm Open Trephine Handle
MVR 20Ga Stiletto Blade
Schockett Double Ended Depressor w/Clip
Hardten Collector Sponge
Medicine Products: